Transtorno mental comum e qualidade de vida em mulheres portadoras de câncer de mama em tratamento com tamoxifeno

Abstract

Breast cancer is one of the most prevalent diseases in the world. Besides being a disease that affects the body drastically, it also causes serious psychological changes due to several factors, which involve from the discovery of the disease to the end of the treatment. Women receiving Tamoxifen face various side effects that can impact their mental health and quality of life. The objective of the study was to investigate the common mental disorder and quality of life in women with breast cancer receiving Tamoxifen, accompanied by an outpatient specialty in Santa Catarina. This is a quantitative cross-cutting study, carried out between 2020 and 2021, involving 22 women. The psychometric scales Self-Reporting Questionnaire and World Health Organization Quality of Life-bref were applied, which measure respectively anxious and depressive symptoms and quality of life, in addition to a participant characterisation questionnaire. Descriptive and frequency analyses were performed in addition to tests by Shapiro-Wilk, Pearson, Spearman, Student T and Mann-Whitney. The findings of this study show that the overall quality of life of the participants was perceived by them as satisfactory, although less so in relation to the body/physical dimension. The Common Mental Disorder was not a concern and is inversely correlated with the quality of life, that is, the better the quality of life, the lower the likelihood of developing Common Mental Disorder. This finding indicates the need to develop VQ-promoting practices, contributing directly to the mental state of these women, taking into account that these factors contribute to the impairment of treatment and the very evolution of the disease.